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Zygomycosis is an increasing threat to patients with human immunodeﬁciency virus (HIV) infection. Zygomycosis (formerly
called mucormycosis) is the fungal infection with Mucor, Rhizopus, or other species that share a common morphology of large
empty pauciseptate hyphae with rare random-angle branching and a collapsed “twisted ribbon” appearance. Morphology allows
a speciﬁc diagnosis on frozen section or smear prior to growth and identiﬁcation of the fungi in culture which makes it improtant
becausetreatmentisdiﬀerentthanthatformorecommonmycosessuchascandidiasisandaspergillosis.Wepresentaninformative
and illustrative case of zygomycosis in a patient with HIV infection and liver transplantation.
1.Introduction
Theincidenceofzygomycosis(formerlyknownasmucormy-
cosis) is increasing in patients with HIV infection [1]. The
incidence of zygomycosis is increasing overall, especially in
patients immunosuppressed for transplantation [2, 3]. Risk
factors for this fungal infection include immunocompro-
mised states, diabetes mellitus, hematologic malignancy, and
neutropenia. The increasing incidence of diabetes mellitus
and malignancies has been suggested as an explanation
for the rise in zygomycosis in patients with HIV infection
[1]. Another factor in the overall increase in zygomycosis
is the use of imidazoles such as voriconazole, particularly
as antifungal prophylaxis in transplant patients, because
voriconazole is ineﬀective against Zygomycetes [2–5].
Zygomycosis is an invasive angiotropic infection with
fungi of the Mucorales order, which includes Mucor species,
Rhizopus species, Rhizomucor species, and multiple others.
The most common form of infection is rhinocerebral, which
is classically associated with poor glycemic control. The
second most common form of infection is pulmonary and
the third disseminated. Other forms of zygomycosis include
cutaneous, gastrointestinal, and renal zygomycosis [6].
Zygomycetes have a distinctive morphology; they have
large hyphae, 5 to 20microns in width. In comparison, the
hyphae of Aspergillus species are 3 to 5microns in width.
Zygomycetes have a very low cellular protein content, giving
their hyphae an empty or hollow appearance on routine
hematoxylin and eosin stain. The hyphae of Zygomycetes
are pauciseptate; they have few septations. The hyphae of
Zygomycetes also have few branchings, and the few they have
are at random angles, including right angles and other nona-
cute angles. In contrast, Aspergillus and most other common
pathogenic fungi have acute-angle branching. Because of
their large size and low-protein content (relative emptiness),
the hyphae of Zygomycetes are frequently collapsed in
tissue sections, creating a characteristic “twisted ribbon”
appearance. The distinctive morphology of Zygomycetes
allows a pathologist to diagnose zygomycosis in a frozen
section or smear prior to a diagnosis by culture. This is
important because early diagnosis is key to better treatment
outcomes and the treatment is diﬀerent than that for much
more common mycoses such as candidiasis and aspergillosis.
The following case is informative and illustrative.
2.CaseReport
This 50-year-old white male with a history of HIV infection
diagnosed 24 years ago, having been on highly active2 Pathology Research International
antiretroviral therapy (HAART) for the last 9 years, had a
history of intravenous drug abuse ending 21 years prior.
He developed end-stage liver disease secondary to hepatitis
C, presumably contracted through intravenous drug abuse.
He also had a remote history of smoking and alcohol use,
a remote right leg deep venous thrombosis, and chronic
pancytopenia.
The patient was hospitalized with decompensated
end-stage liver disease and hepatorenal syndrome. He was
found to have a lupus anticoagulant. The patient developed
heart failure and pulmonary edema. His CD4+ T-cell count
was 108/cumm. He improved clinically over the course of
several weeks and ﬁnally was deemed a candidate for liver
transplantation.
Following transplantation, he was immunosuppressed
due to his renal failure with a calcineurin-sparing protocol
including basiliximab (Simulect), mycophenolate, and pred-
nisone (20mg/day). He was also treated with daptomycin,
dapsone, acyclovir, and voriconazole. His HAART was held
during the ﬁrst few days after transplant. Immediately after
transplant, chest X-ray showed near-complete resolution of
pulmonary edema and small areas of atelectasis in mid
and lower left lung. That evening, the patient’s temperature
was 38.5degrees, heart rate 82/minute, blood pressure
109/47mmHg, pulmonary artery pressure 31/18mmHg,
cardiac output 13L/min, systemic vascular resistance index
(SVRI) 705, and respirations 16/minute. He was extubated.
On postoperative day 1, the patient was afebrile, but
vasodilated, with blood pressure 84/52mmHg, and nore-
pinephrine was started. He had mild crackles on lung exam-
ination. His white blood cell (WBC) count was 600/cumm
(61% neutrophils, 4% bands, 20% monocytes, 10% lym-
phocytes, 5% atypical lymphocytes), hemoglobin 7.9g/dL,
platelets 28,000/cumm, and international normalized ratio
(INR) 3.3. Chest X-ray showed mild interstitial pulmonary
edema and increased atelectasis at the left base. He was
started on ﬁlgrastim.
On day 2, the patient was afebrile, with respira-
tions 26/minute, blood pressure 92/55mmHg (on nore-
pinephrine), cardiac output 13L/minute, and SVRI 350. He
had labored breathing. Chest X-ray showed interstitial right
lung edema and a large left pleural eﬀusion with atelectasis
involving the entire left lung. The patient was placed on
biphasic positive airway pressure (BiPAP), and repeat chest
X-ray showed considerable expansion of the left-upper lobe.
His creatinine was 3.9mg/dL, and continuous venovenous
hemodialysiswasstarted.Onday4,thepatientwasintubated
for mental status changes and respiratory insuﬃciency. He
wasstartedonhydrocortisone.Onday5,thepatientrequired
increasing doses of norepinephrine and the addition of vaso-
pressin. Gram stain of bronchoalveolar lavage (BAL) showed
rare white blood cells. Piperacillin/tazobactam (Zosyn) was
added.
On day 6, the patient required mechanical ventila-
tion with 50% oxygen. He had a “signiﬁcant amount
of secretions.” Computed tomography showed extensive
airspace consolidation superimposed on atelectasis through-
out dependent portions of the left lung associated with
mucus plugging in the left-lower lobe; there was also a
moderate left pleural eﬀusion, small right pleural and
pericardialeﬀusions,andmild-moderateascites.BALculture
from day 5 yielded >100,000/mL Enterococcus species. Tige-
cycline and caspofungin were added.
On postoperative day 7, the patient’s temperature was
34degrees, heart rate 69/minute, blood pressure 96/
60mmHg, respiratory rate 16/minute, and saturation 100%
on mechanical ventilation with 40% oxygen. The patient’s
HAART was restarted. Vancomycin was added. His bilirubin
was 3.5mg/dL, aspartate aminotransferase (AST) 142IU/L,
lactate dehydrogenase (LDH) 672IU/L, creatine phosphok-
inase (CPK) 1526IU/L, creatinine 0.8mg/dL, WBC count
10,300/cumm (neutrophils 76%, bands 23%, lymphocytes
1%), hemoglobin 6.2g/dL, platelets 33,000/cumm, and
INR 1.7. Chest X-ray showed a large left pleural eﬀusion,
airspace consolidation of the left lung and mild right
perihilar interstitial pulmonary edema. Shortly before mid-
night, the patient suddenly developed pulseless electrical
activity, and he could not be resuscitated. His glucose had
been 125–180mg/dL postoperatively. Blood culture from
day 6 was later reported positive for vancomycin-resistant
Enterococcus faecium.
Postmortem examination revealed massive disseminated
zygomycosis involving both lungs, pericardium, coronary
arteries and veins, myocardium, spleen, lymph nodes, bone
marrow, stomach, and right kidney. Autopsy spleen culture
was positive for Rhizomucor species. There was massive
pulmonary consolidation, with left lung weight 1420grams
(normal up to 480grams), and right lung weight 1130grams
(normal up to 570grams). Autopsy revealed infected throm-
bosisofthemainleft-lower-lobepulmonaryarterywithmas-
sive parenchymal zygomycosis, infarction, and hemorrhage
(Figures 1 and 2). The left pleural cavity contained 1200mL
of hemorrhagic eﬀusion. The right-upper-lobe pulmonary
artery had an infected thrombus associated with extensive
parenchymal zygomycosis of central right-upper lobe. There
wasseverecoronaryatherosclerosiswithuptoapproximately
80% stenosis of the left circumﬂex coronary artery and
infected thrombosis of left anterior descending coronary
artery and multiple branches of this artery (Figures 3
and 4). Autopsy disclosed severe pericarditis with hemor-
rhagic pericardial eﬀu s i o n( 1 0 5m L ) .T h el i v e rs h o w e dm o d -
erate canalicular cholestasis, mild acute intrahepatic peri-
cholangitis, and moderate centrolobular ischemic changes.
There were 1800mL of hemorrhagic ascites.
Overall, the clinical history and autopsy ﬁndings in this
case suggested that the cause of death was disseminated
zygomycosisduetotheimmunosuppressionrequiredbyliver
transplantation for hepatitis C virus infection together with
the immunocompromise of HIV infection. Coagulopathy,
severe coronary atherosclerosis, and acute renal failure were
regarded as contributing causes of death.
3. Discussion
This case illustrates the diagnostic morphologic features of
zygomycosis, the diﬃculty of diagnosing a rare condition
with nonspeciﬁc clinical manifestations, and the valuePathology Research International 3
Figure 1: Pulmonary artery containing numerous large fungal
hyphaewithminimalseptationandbranching,somewithanempty
appearance (H&E, 200x).
Figure 2: Fungal hyphae with prominent collapsed conﬁguration
resembling twisted ribbon (H&E, 400x).
of autopsy to reveal undiagnosed causes of death. With
the superabundance of sophisticated and high-technology
diagnostic testing available, it is widely assumed that autopsy
rarely reveals any important undetected conditions, but the
hypothesis that only the lack of testing leaves important
conditions undiagnosed was recently tested by a study
comparing the rate of ﬁnding major undiagnosed conditions
at autopsy in patients who died in intensive care units,
inpatient surgical units, and nursing homes [7]. The rate
of ﬁnding major undiagnosed conditions was 27.8% for the
medical intensive care unit patients, 32.7% for the surgery
service patients, and 31.3% for the nursing home patients
(P = .84). In addition, the investigators found no statistical
diﬀerence in the complexity of workup in discrepant and
nondiscrepant cases in each clinical setting.
Autopsies of patients with HIV infection continue to
disclose major undiagnosed conditions many years after the
disease was ﬁrst recognized. A study of 1,630 autopsies of
patients with HIV infection between 1984 and 2002 found
that 297 (18.2%) revealed invasive fungal infections, which
were causes of death in 103 cases, and 38 of these fatal
invasivefungalinfectionswereundiagnosedantemortem[1].
Figure 3: Coronary artery thrombosed with clot containing
unusual basophilic strands not typical of ﬁbrin (H&E, 40x).
Figure 4: Coronary artery clot containing numerous large, rel-
atively open, pauciseptate fungal hyphae typical of Zygomycetes
(H&E, 200x).
In this series, zygomycosis was rare; there were no cases of
zygomycosis in the 1,036 autopsies between 1984 and 1993,
but there were 2 cases in the 594 autopsies between 1994 and
2002 (P = .42). Zygomycosisis arareopportunistic infection
in patients whose only risk factor is HIV infection.
Due to the eﬃcacy of new combined antiretroviral thera-
py in the treatment of HIV infection, more of these patients
are living long enough to succumb to other diseases such
as hepatitis C. Transplantation has become an accepted
treatment for end-stage organ disease in patients with HIV
infection [8–11]. As a result, increasing numbers of patients
with HIV infection are candidates for transplantation.
Although one might assume that HIV-infected patients
would not need immunosuppression to prevent transplant
rejection, a study of 150 kidney transplant recipients with
CD4+ T-cell counts above 200/cumm found that they had
a higher-than-expected rate of rejection, reaching 41% at 3
years, demonstrating the need for immunosuppression even
in immunocompromised HIV-infected patients [11]. Many
patients who acquired HIV infection from intravenous drug
use also acquired hepatitis C via the same route, and when
they develop end-stage liver disease from hepatitis C, liver4 Pathology Research International
transplantation becomes their hope for extended survival
from their liver disease. Liver transplantation for such
patients has long been performed at the University of Pitts-
burgh Medical Center without a disproportionate increase
in opportunistic infections since 1997 [12]. Zygomycosis is
an increasing, but still rare, opportunistic infection in trans-
plant patients. In a study of 1208 invasive fungal infections
among1063solidorgantransplantrecipientsbetweenMarch
2001andMarch2006, zygomycosisaccountedforonly2% of
the infections [13].
In the case we are reporting, the patient had multiple risk
factors for zygomycosis: HIV infection, immunosuppression
for transplantation, and neutropenia. He did not, however,
have diabetes mellitus, and he had good glycemic control
despite critical illness. He also did not have the most
common rhinocerebral form of zygomycosis involving the
paranasal sinuses, base of the skull, and brain. The clinical
history and autopsy ﬁndings suggest that he developed
disseminated infection starting with a pulmonary infection,
but radiologic imaging of the chest and bronchoscopy with
bronchoalveolar lavage failed to reveal the diagnosis. In this
case, it is diﬃcult to imagine how an antemortem diagnosis
might have been made, especially early enough to alter the
outcome. The ﬁrst step toward making the diagnosis in other
HIV patients is an awareness that zygomycosis is an increas-
ingly likely opportunistic fungal infection in these patients.
A review of zygomycosis in patients with HIV infection
suggested that it is more common in those with a history
of intravenous drug use and that transient neutropenia may
be a critical factor in allowing this opportunistic infection to
occur [14].
Successful treatment of zygomycosis generally requires
intravenous amphotericin B, and surgically accessible infec-
tion with debridement improves the chances of success [4,
6, 14]. Posaconazole is a new orally administered antifungal
agent with eﬃcacy against Zygomycetes, which can play a
role in eﬀective therapy [4]. Successful therapy depends,
however, on early diagnosis. Early diagnosis is possible with
frozen section or smear and an astute pathologist [15].
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